推荐产品
等级
pharmaceutical primary standard
API类
talampicillin
制造商/商品名称
EDQM
应用
pharmaceutical (small molecule)
包装形式
neat
储存温度
2-8°C
SMILES字符串
S1[C@H]2N([C@H](C1(C)C)C(=O)OC4OC(=O)c5c4cccc5)C(=O)[C@H]2NC(=O)[C@H](N)c3ccccc3.[Cl-].[H+]
InChI
1S/C24H23N3O6S.ClH/c1-24(2)17(22(31)33-23-14-11-7-6-10-13(14)21(30)32-23)27-19(29)16(20(27)34-24)26-18(28)15(25)12-8-4-3-5-9-12;/h3-11,15-17,20,23H,25H2,1-2H3,(H,26,28);1H/t15-,16-,17+,20-,23?;/m1./s1
InChI key
PAZSYTCTHYSIAO-WVFSJLEKSA-N
一般描述
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
应用
Talampicillin hydrochloride EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
包装
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
其他说明
Sales restrictions may apply.
警示用语:
Danger
危险分类
Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3
靶器官
Respiratory system
储存分类代码
11 - Combustible Solids
WGK
WGK 3
法规信息
监管及禁止进口产品
[Clinical evaluation of Yamacillin 250mg in dental infections].
Shikai tenbo = Dental outlook, 58(2), 383-391 (1981-08-01)
[In vitro hydrolysis of an ampicillin ester. I. Microbiologic evaluation].
N M Angelini et al.
Revista latinoamericana de microbiologia, 25(2), 109-112 (1983-04-01)
T Yoshii et al.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 91(6), 643-648 (2001-06-13)
The purpose of this study was to evaluate various oral antimicrobial agent levels in tooth extraction sites. The concentration of dental alveolar blood in extraction wounds after the oral administration of talampicillin (500 mg), cefaclor (500 mg), cefteram pivoxil (200
N A Nguyen et al.
Pharmaceutical research, 5(5), 288-296 (1988-05-01)
The utilization time for a parenteral prodrug solution with a bioavailable fraction of unity was defined as the time during which the total of the prodrug concentration and the drug concentration equals or exceeds 90% of the initial prodrug concentration.
K C Mohanty et al.
The British journal of venereal diseases, 58(3), 180-181 (1982-06-01)
Four hundred and sixty women with uncomplicated gonorrhea were treated with a single oral dose of 1.5 g talampicillin. The success rate among those who attended for at least one follow-up examination after treatment was 99.14%. The antibiotic was well
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门